Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 10.6K | $1.18M | $111.35 | Aug 2, 2024 | by Trust |
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 5.32K | $593K | $111.35 | Aug 6, 2024 | Direct |
Cerevel Therapeutics Holdings, Inc. | Director | Common Stock | 0 | $0 | $41.18 | Aug 1, 2024 | Direct |
Aptinyx Inc. | EXECUTIVE CHAIRMAN OF THE BOD, Director | Stock Option (Right to Buy) | 420K | Jan 3, 2023 | Direct | ||
Eton Pharmaceuticals, Inc. | Director | Stock Option (Right to buy) | 165K | Feb 13, 2024 | Direct | ||
Cerevel Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 0 | Aug 1, 2024 | Direct |